A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

Diabetologia

Volumn 56, Issue 11, 2013, Pages 2524-2537

  Moreno Navarrete, José María ^a,b   Escoté, Xavier ^c,d   Ortega, Francisco ^a,b   Serino, Matteo ^e   Campbell, Mark ^f   Michalski, Marie Caroline ^g   Laville, Martine ^g   Xifra, Gemma ^a,b   Luche, Elodie ^e   Domingo, Pere ^h   Sabater, Mónica ^a,b   Pardo, Gerard ^a,b   Waget, Aurelie ^e   Salvador, Javier ^b,i   Giralt, Marta ^b,j   Rodriguez Hermosa, Jose I ^k   Camps, Marta ^j   Kolditz, Catherine I ^e   Viguerie, Nathalie ^e   Galitzky, Jean ^e   Decaunes, Pauline ^e   Ricart, Wifredo ^a,b   Frühbeck, Gema ^b,i   Villarroya, Francesc ^b,j   Mingrone, Geltrude ^l   Langin, Dominique ^e   Zorzano, Antonio ^d,j,m   Vidal, Hubert ^g   Vendrell, Joan ^c,d   Burcelin, Remy ^e   Vidal Puig, Antonio ^f   Fernández Real, José Manuel ^a,b   more..

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e INSERM   (France)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITÉ LYON 1   (France)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

^j UNIVERSITY OF BARCELONA   (Spain)

^k IdIBGi ^*  (Spain)

^l CATHOLIC UNIVERSITY   (Italy)

^m INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

more..

Author keywords

Adipogenesis; Adipose tissue; Inflammation; Lipopolysaccharide binding protein; Obesity

Indexed keywords

LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; LIPODYSTROPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WEIGHT GAIN;

ACUTE-PHASE PROTEINS; ADIPOCYTES; ADIPOSE TISSUE; ADULT; ANIMALS; CARRIER PROTEINS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MIDDLE AGED; OBESITY; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885852940     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3015-9     Document Type: Article

References (42)

1. Wormser D, Kaptoge S, Di Angelantonio E et al (2011) Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377:1085-1095
2. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97
3. Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772
4. Cani PD, Bibiloni R, Knauf C et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481
5. Lassenius MI, Pietiläinen KH, Kaartinen K et al (2011) Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34:1809-1815
6. Osto M, Zini E, Franchini M et al (2011) Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats. Endocrinology 152:804-815
7. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340-5351
8. Creely SJ, McTernan PG, Kusminski CM et al (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747
9. Schäffler A, Schölmerich J (2010) Innate immunity and adipose tissue biology. Trends Immunol 31:228-235
10. Fernández-Real JM, Pérez del Pulgar S, Luche E et al (2011) CD14 modulates inflammation-driven insulin resistance. Diabetes 60:2179-2186
11. Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113-116
12. Tobias PS, Soldau K, Ulevitch RJ (1989) Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264:10867-10871
13. Hailman E, Lichenstein HS, Wurfel MM et al (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269-277
14. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW (2004) Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 89:4062-4068
15. Ruiz AG, Casafont F, Crespo J et al (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17:1374-1380
16. Sun L, Yu Z, Ye X et al (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925-1932
17. Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 8:e54600
18. Moreno-Navarrete JM, Ortega F, Serino M et al (2012) Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond) 36:1442-1449
19. Nakarai H, Yamashita A, Nagayasu S et al (2012) Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate Immun 18:164-170
20. Ge Q, Gerard J, Noel L, Scroyen I, Brichard SM (2012) MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation. Endocrinology 153:5285-5296
21. Giralt M, Domingo P, Guallar JP et al (2006) HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Antivir Ther 11:729-740
22. Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025-2031
23. Alligier M, Meugnier E, Debard C et al (2012) Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J Clin Endocrinol Metab 97:183-192
24. Moreno-Navarrete JM, Ortega FJ, Rodríguez-Hermosa JI et al (2011) OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects. Diabetes 60:168-176
25. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B (2002) Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834-E842
26. Sulpice T, Prunet-Marcassus B, Molveaux C et al (2009) An adiponectin-like molecule with antidiabetic properties. Endocrinology 150:4493-4501
27. Medina-Gomez G, Gray SL, Yetukuri L et al (2007) PPARg2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLos Gen 27:e64
28. Curat CA, Miranville A, Sengenès C et al (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53:1285-1292
29. Gutsmann T, Müller M, Carroll SF, MacKenzie RC, Wiese A, Seydel U (2001) Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 69:6942-6950
30. Bezaire V, Mairal A, Ribet C et al (2009) Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem 284:18282-18291
31. Neville MJ, Collins JM, Gloyn AL, McCarthy MI, Karpe F (2011) Comprehensive human adipose tissue mRNA and microRNA endogenous control selection for quantitative real-time-PCR normalization. Obesity (Silver Spring) 19:888-892
32. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180:1025-1035
33. Kirschning CJ, Au-Young J, Lamping N et al (1997) Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 46:416-425
34. Kirschning CJ, Unbehaun A, Fiedler G et al (1997) The transcriptional activation pattern of lipopolysaccharide binding protein (LBP) involving transcription factors AP-1 and C/EBP beta. Immunobiology 198:124-135
35. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11-18
36. Vitseva OI, Tanriverdi K, Tchkonia TT et al (2008) Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 16:932-937
37. Gillum MP, Kotas ME, Erion DM et al (2011) SirT1 regulates adipose tissue inflammation. Diabetes 60:3235-3245
38. Lê KA, Mahurkar S, Alderete TL et al (2011) Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes 60:2802-2809
39. Suganami T, Tanimoto-Koyama K, Nishida J et al (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91
40. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025
41. Youssef-Elabd EM, McGee KC, Tripathi G et al (2012) Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. J Nutr Biochem 23:39-50
42. Huang S, Rutkowsky JM, Snodgrass RG et al (2012) Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 53:2002-2013